Show
Sort by
-
The subgroups of the phase III RECOURSE trial of trifluridine/tipiracil (TAS-102) versus placebo with best supportive care in patients with metastatic colorectal cancer
-
No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands
-
Radiotherapy access in Belgium : how far are we from evidence-based utilisation?
-
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma
-
The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy
-
Menopausal hormone therapy and cancer risk : an overestimated risk?
-
Sunitinib (SU11248) in patients with chemo naive extensive small cell lung cancer or who have a 'chemosensitive' relapse: a single-arm phase II study (EORTC-08061)
-
Risk stratification in febrile neutropenic episodes in adolescent/young adult patients with cancer
-
Melanoma burden by melanoma stage : assessment through a disease transition model
-
- journalArticle
- A1
- open access
Cost-effectiveness analysis in melanoma detection: a transition model applied to dermoscopy